劉倫濤，研究員，博士生導(dǎo)師，協(xié)和準(zhǔn)長(zhǎng)聘助理教授，2023年獲得天津市杰青，2025年獲得國(guó)家青年人才項(xiàng)目。院校引進(jìn)人才，2023年3月加入院校，曾于2020年9月至2023年3月在福州大學(xué)攻讀博士后。

聚焦腫瘤放療增敏與輻射防護(hù)的關(guān)鍵臨床問(wèn)題，利用微納米技術(shù)，進(jìn)行放療增敏藥物、輻射防護(hù)藥物與醫(yī)療器械的開(kāi)發(fā)。近五年，以第一作者或通訊作者在Chem、Nat Commun、STTT、Angew Chem Int Ed等期刊發(fā)表SCI論文20余篇，申請(qǐng)專(zhuān)利9項(xiàng)，授權(quán)8項(xiàng)，主持國(guó)自然面上等多項(xiàng)國(guó)家及省部級(jí)項(xiàng)目；目前，開(kāi)發(fā)的釋氫凝膠貼片在放療病人皮膚輻射防護(hù)中展現(xiàn)出了突出效果，該產(chǎn)品也獲得了國(guó)家生物材料大學(xué)生創(chuàng)新大賽一等獎(jiǎng)等多項(xiàng)創(chuàng)業(yè)獎(jiǎng)項(xiàng)。

久久综合九色欧美综合狠狠_伊人热热久久原色播放WWW_成A人片亚洲日本久久_久久不见久久见免费影院www日本_97久久精品人人做人人爽,又色又爽又黄的视频在线观看,狼群影院视频在线观看高清版,亚洲AV无码精品网站性色,国产乱码久久久久久红粉影视,精品国产乱码久久久久久一区二区,国产精品免费视频网站,国产A级毛片久久久久久精品,一级特黄高清aaaa大片,亚洲中文字幕欧美一区,久久精品国产99久久狂热,黑人巨大精品欧美_黑人巨大精品欧美黑寡妇_黑人巨大精品欧美一区二区_黑人巨大精品欧美一区二区免费_黑人巨大跨种族video_黑人巨大无码中文字幕无码_黑人巨茎大战俄罗斯美女_黑人巨茎大战俄罗斯美女,中文字幕av不卡|亚洲欧美国产另类|天天干在线播放|日韩黄视频|欧美七区|可以免费看毛片的网站|黄色片在线|国产精品96久久久久久

1. Xianggui Yin#, Changfen Bi*, Yuanfang Chen, Xueyin Hu, Guangyou Shi, Shuqin Li, Wen Zhang, Longbo Ma, Saijun Fan*, Luntao Liu*. Efficient active hydrogen delivery for drug-free radiation enteritis therapy in mice. Nat Commun. 2025, 16, 9229–9230. (IF=15.7)

2. Yue Shang#, Xueyin Hu#, Meixia Ren#, Longbo Ma, Xiaoyu Zhao, Cong Gao, Lumeng Zhang, Shuqin Li, Luntao Liu*, Bingwen Zou*, Saijun Fan*. Understanding the toxicity induced by radiation-triggered neuroinflammation and the on-demand design of targeted peptide nanodrugs. Sig Transduct Target Ther. 2025, 10, 286–309. (IF=52.7)

3. Wen Zhang#, Xueyin Hu#, Wei Cheng, Lumeng Zhang, Yuanfang Chen*, Qinrui Fu*, Luntao Liu*, Saijun Fan. Harnessing nanomaterials to precisely regulate the immunosuppressive tumor microenvironment for enhanced immunotherapy. BMEMat. 2025, e70019. (IF=15.5)

4. Lei Cao#, Chuang Liu, Chuan Mu, Qingqing Li, Min Wu*, Luntao Liu*, Bin Liu*. Ultrasound-responsive carbon monoxide microneedle for enhanced healing of infected diabetic wounds. Adv Healthcare Mater. 2025, 14, 2402910. (IF=9.6)

5. Liu Yu#, Yiqiu Fu, Rourou Miao, Jiahui Cao, Fan Zhang, Luntao Liu*, Lin Mei*, Meitong Ou*. Regulatory T Cells and their derived cell pharmaceuticals as emerging therapeutics against autoimmune diseases. Adv Funct Mater. 2024, 34, 2405133. (IF=19)

6. Jiamin Ye#, Yueyue Fan, Yaoguang She, Jiacheng Shi, Yiwen Yang, Xue Yuan, Ruiyan Li, Jingwen Han,?Luntao Liu*,?Yong Kang*, Xiaoyuan Ji*. Biomimetic self-propelled asymmetric nanomotors for cascade-targeted treatment of neurological inflammation. Adv Sci. 2024, 11, 2310211 (IF=14.1, ESI)

7. Qinrui Fu#, Leilei Yu, Meihua Zhang, Shuqin Li,?Luntao Liu*?Engineering nanosystems for ROS-bridged cancer cascade therapy. Chem Eng J. 2023, 473, 145415. (IF=13.4)

8. Luntao Liu#, Shuqin Li, Kaiqiong Yang, Zhongxiang Chen, Qingqing Li, Liting Zheng, Zongsheng Wu, Xuan Zhang,?Lichao Su, Ying Wu, Jibin Song*. Drug-free antimicrobial nanomotor for precise treatment of multidrug-resistant bacterial infections. Nano Lett. 2023, 23, 3929-3938. (IF=9.6)

9. Shuqin Li#, Hongqi Huo, Xing Gao,?Luntao Liu*, Shumin Wang, Jiamin Ye, Jing Mu*, Jibin Song*.?Engineering janus gold nanorod-titania heterostructures with enhanced photocatalytic antibacterial activity against multidrug-resistant bacterial infection. Nano Res. 2023, 16, 2049–2058. (IF=9.9)

10. Luntao Liu#, Ying Wu, Jiamin Ye, Qinrui Fu, Lichao Su, Zongsheng Wu, Ji Feng, Zhongxiang Chen, Jibin Song*. Synthesis of magnesium nanoparticle for NIR-II-photoacoustic-imaging-guided synergistic burst-like and H₂?cancer therapy. Chem. 2022, 8, 11, 2990–3007. (IF=23.5)